NovelStem International Corp. (NSTM)

Market Cap	468.82K -96.6%
Revenue (ttm)	3.00K -75.0%
Net Income	2.31M
EPS	0.05
Shares Out	46.88M
PE Ratio	0.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	98,105
Open	0.0100
Previous Close	0.0100
Day's Range	0.0100 - 0.0100
52-Week Range	0.0081 - 0.0394
Beta	2.31
RSI	44.54
Earnings Date	Apr 2, 2026

About NovelStem International

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: NSTM

Financial Performance

In 2024, NovelStem International's revenue was $12,000, a change of 0.00% compared to the previous year's $12,000. Losses were -$3.23 million, -22.79% less than in 2023.